38.6c New Delhi, India, Thursday, December 01, 2022
Top Stories
Interviews Know The Law Book Reviews Videos
About Us Contact Us
Top Stories

Ban On Oxytocin Suspended For One Month By Delhi HC

By Lawstreet News Network      Sep 01, 2018      0 Comments      396 Views

On Friday (August 31st, 2018), the Delhi High Court suspended the ban that was imposed by the Centre on the manufacturing and distribution of the hormone drug oxytocin by the private companies. Oxytocin is a uterine stimulant hormone which is used to induce labour during childbirth and control bleeding after it. It is also used to help abort the foetus in case of incomplete abortion or miscarriage.

A Bench comprising of Justice S. Ravindra Bhat and Justice A.K. Chawla gave an interim order on pleas challenging the government’s ban on the drug in the market and listed the case for September 12, 2018, for further arguments.

Earlier in April 2018, the government restricted private companies from manufacturing or supplying the drug (oxytocin) to stop its alleged misuse in the dairy sector, where it was injected into dairy animals to increase their milk production.

As per the notification issued by the Centre, Karnataka Antibiotics and Pharmaceuticals Ltd (KAPL), a government company, was solely allowed to manufacture the drug to meet the needs of the country.

The court noted that when the decision was taken in February 2018 to put a stop on the sale of oxytocin, KAPL was not a licenced manufacturer and the license was issued to them later in April 2018.

The court was hearing pleas filed by NGO - All India Drug Action Network amongst others which contended that it would not be advisable to depend on one company alone, especially when it allegedly has not made the product earlier.



Tags:
Delhi High Court
Share this article:


Lawstreet News Network
Editor
     



Leave a feedback about this




Related Posts
View All

TRENDING NEWS


TOP STORIES

Legal Insiders
Law college professor ends life by suicide
23 days ago

ADVERTISEMENT


Lawstreet Advertisement

Signup for Our Newsletter

Get Exclusive access to members only content by email